Common Contracts
3 similar License Agreement contracts
FIRST/SECOND/THIRD] AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • November 6th, 2017 • England
AGREEMENT (this “Amendment”) is made as of (the “Amendment Effective Date”) by and among Gilead Sciences, Inc. a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, California 94404, USA (“Gilead”), the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at Rue de Varembé, 7, 1202 Geneva, Switzerland (“MPP”), and
FIRST AMENDMENT TOLicense Agreement • November 6th, 2017 • England
(the “Amendment Effective Date”) by and among Gilead Sciences, Inc. a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, California 94404, USA (“Gilead”), the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at Rue de Varembé 7, 1202 Geneva, Switzerland (“MPP”), and a company registered under the laws of India, and having a registered office at
FIRST AMENDMENT TOLicense Agreement • November 6th, 2017 • England
(the “Amendment Effective Date”) by and among Gilead Sciences, Inc. a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, California 94404, USA (“Gilead”), the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at Rue de Varembé 7, 1202 Geneva, Switzerland (“MPP”), and a company registered under the laws of South Africa, and having a registered office at
